November 21, 2018 Single-pass tangential flow filtration is revolutionizing how tangential flow filtration is implemented in biotech, vaccine, blood plasma and other applications. Pall has now made it even easier to implement this breakthrough patented technology into your process. As with the original Cadence SPTFF modules, the Cadence Inline Concentrator (ILC) is now available with... Read more
November 15, 2018 The new and improved iCELLis 500+ bioreactor system will simplify large scale cGMP production of virus for vaccines or gene therapy. New features provide enhanced robust control, reliability, and sustainability of high-density adherent cell growth in an automated format. Boasting a new stainless steel frame and temperature control unit (TCU), the... Read more
PORT WASHINGTON, N.Y., Oct. 3, 2018 /PRNewswire/ — Pall Corporation, a global leader in filtration, separation and purification, has progressed a strategic partnership with the University College London (UCL) Biochemical Engineering department with the creation of the UCL-Pall Biotech Centre of Excellence (CoE) for research and training. The UCL-Pall Biotech CoE will be operational from September 2018 through 2024 with a management committee... Read more
PORT WASHINGTON, N.Y., Sept. 12, 2018 /PRNewswire/ — Pall Corporation, a global leader in filtration, separation and purification, has announced a strategic partnership between its Pall Biotech business unit and Aetos Biologics, a biosimilar cell line development company. The companies will collaborate to offer biosimilar manufacturing solutions to the global biosimilars market. Pall Biotech will... Read more
September 10, 2018 KANEKA♦ KanCapA 3G sorbent comprises a recombinant Protein A ligand covalently attached to a rigid cellulose matrix. This ensures stability over a high number of cycles and provides high flow performance at low pressure making the sorbent compatible with the process requirements for large scale mAb manufacture in both batch and continuous processing using... Read more
PORT WASHINGTON, NY – September 4, 2018: Pall Corporation, a global leader in filtration, separation and purification, has formed a strategic partnership with Celltheon Corporation, an experienced cell line and expression technology platform development company. This partnership aligns Pall Biotech equipment and consumables with the Celltheon SMART™ Expression Platform to deliver integrated manufacturing solutions for customers developing... Read more
PORT WASHINGTON, N.Y., July 18, 2018 /PRNewswire/ — Pall Corporation, a global leader in filtration, separation and purification, is pleased to announce the extension of a consumables distribution agreement with KANEKA Corporation. In addition to flagship KANEKA KanCapA Protein A chromatography sorbents, the Pall Biotech business unit now features the company’s next generation KANEKA KanCapA 3G sorbent for the primary capture... Read more
02 July 2018 Leica Microsystems launches a new cleanliness analysis software The new Cleanliness Expert software from Leica Microsystems is now available. It is an easy-to-use, optimal cleanliness solution to provide you with reliable, repeatable analysis results for your specific application needs. Benefit from an exceptional, unique, customizable workflow solution in this new version: Save... Read more
PORT WASHINGTON, N.Y., April 16, 2018 /PRNewswire/ — Pall Corporation, a global leader in filtration, separation and purification, announced a strategic collaboration between its Biotech business unit and Artesyn Biosolutions, a leading innovator in single-use components and fluid management technologies. The agreement will encompass a co-development partnership, delivering complete solutions from clinical to commercial-scale for single-use automated bioprocessing... Read more